Jack Nathan Medical Corp. (JNHMF)
OTCMKTS · Delayed Price · Currency is USD
0.0036
-0.0001 (-2.70%)
At close: Jun 2, 2025
Blueprint Medicines Income Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2019 - 2020 |
| 8.71 | 6.89 | 15.49 | 9.64 | 3.85 | Upgrade | |
Revenue Growth (YoY) | 26.41% | -55.53% | 60.68% | 150.21% | 6.50% | Upgrade |
Cost of Revenue | 1.34 | 1.56 | 3.04 | 2.98 | 0.8 | Upgrade |
Gross Profit | 7.37 | 5.33 | 12.44 | 6.66 | 3.05 | Upgrade |
Selling, General & Admin | 9.47 | 6.57 | 15.45 | 9.67 | 2.77 | Upgrade |
Research & Development | - | - | - | 0.55 | 0.1 | Upgrade |
Operating Expenses | 9.76 | 7.51 | 17.64 | 13.2 | 3.86 | Upgrade |
Operating Income | -2.39 | -2.18 | -5.2 | -6.55 | -0.81 | Upgrade |
Interest Expense | -0.06 | -0.03 | -0.41 | -0.18 | -0.04 | Upgrade |
Interest & Investment Income | 0.04 | 0.06 | 0.01 | 0.04 | 0.02 | Upgrade |
Currency Exchange Gain (Loss) | -0.12 | 0.14 | 0.21 | -0.05 | -0.08 | Upgrade |
Other Non Operating Income (Expenses) | 0.02 | -0.12 | -0.14 | -0.36 | -0.07 | Upgrade |
EBT Excluding Unusual Items | -2.51 | -2.14 | -5.53 | -7.11 | -0.97 | Upgrade |
Merger & Restructuring Charges | - | - | -0.25 | -0.6 | -0.1 | Upgrade |
Impairment of Goodwill | - | - | -1.01 | -0.96 | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | -0.59 | Upgrade |
Asset Writedown | - | - | -0.4 | - | - | Upgrade |
Other Unusual Items | - | - | 0.2 | 0.43 | -8.63 | Upgrade |
Pretax Income | -2.51 | -2.14 | -6.99 | -8.23 | -10.29 | Upgrade |
Income Tax Expense | 0.02 | -0.81 | -0.09 | -0.22 | -0.38 | Upgrade |
Earnings From Continuing Operations | -2.53 | -1.33 | -6.9 | -8.02 | -9.91 | Upgrade |
Earnings From Discontinued Operations | 10 | -5.3 | - | - | - | Upgrade |
Net Income to Company | 7.46 | -6.64 | -6.9 | -8.02 | -9.91 | Upgrade |
Minority Interest in Earnings | - | - | - | 0.21 | 0.01 | Upgrade |
Net Income | 7.46 | -6.64 | -6.9 | -7.81 | -9.9 | Upgrade |
Net Income to Common | 7.46 | -6.64 | -6.9 | -7.81 | -9.9 | Upgrade |
Shares Outstanding (Basic) | 87 | 86 | 84 | 82 | 52 | Upgrade |
Shares Outstanding (Diluted) | 87 | 86 | 84 | 82 | 52 | Upgrade |
Shares Change (YoY) | 2.22% | 1.47% | 2.51% | 59.28% | 16.28% | Upgrade |
EPS (Basic) | 0.09 | -0.08 | -0.08 | -0.09 | -0.19 | Upgrade |
EPS (Diluted) | 0.08 | -0.08 | -0.08 | -0.10 | -0.19 | Upgrade |
Free Cash Flow | -7.54 | -10.2 | -4.59 | -5.29 | -1.31 | Upgrade |
Free Cash Flow Per Share | -0.09 | -0.12 | -0.05 | -0.06 | -0.03 | Upgrade |
Gross Margin | 84.66% | 77.39% | 80.34% | 69.05% | 79.19% | Upgrade |
Operating Margin | -27.45% | -31.71% | -33.57% | -67.95% | -20.91% | Upgrade |
Profit Margin | 85.74% | -96.35% | -44.57% | -81.00% | -257.05% | Upgrade |
Free Cash Flow Margin | -86.62% | -148.05% | -29.64% | -54.90% | -33.98% | Upgrade |
EBITDA | -1.54 | -1.29 | -4.41 | -6.1 | -0.7 | Upgrade |
EBITDA Margin | -17.68% | -18.79% | -28.49% | -63.33% | -18.19% | Upgrade |
D&A For EBITDA | 0.85 | 0.89 | 0.79 | 0.44 | 0.1 | Upgrade |
EBIT | -2.39 | -2.18 | -5.2 | -6.55 | -0.81 | Upgrade |
EBIT Margin | -27.45% | -31.71% | -33.57% | -67.95% | -20.91% | Upgrade |
Advertising Expenses | 0.26 | 0.38 | 0.26 | 0.43 | 0.24 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.